Publikationen von Matthias Dobbelstein

Stegmann, K. M.; Dickmanns, A.; Fuchs, H. L.; Scheibner, D.; Mohl, B.-P.; Moeselaken, F. R.; Reineking, W.; Störk, T.; Volz, A.; Beer, P. A. et al.; Parker, A. E.; Pilchova, V.; Meyer zu Natrup, C.; von Köckritz-Blickwede, M.; Baumgärtner, W.; Balkema-Buschmann, A.; Dobbelstein, M.: Synergistic interference with SARS-CoV-2 replication by molnupiravir-derived N⁴-hydroxycytidine and inhibitors of CTP synthetase in cell culture. Virology 610, 110598 (2025)

Jansen, J.; Dobbelstein, M.: MDM4 exon skipping upon dysfunctional ribosome assembly. Trends in Cell Biology 35 (7), S. 544 - 547 (2025)

Schrell, L.; Fuchs, H. L.; Dickmanns, A.; Scheibner, D.; Olejnik, J.; Hume, A. J.; Reineking, W.; Störk, T.; Müller, M.; Graaf-Rau, A. et al.; Diederich, S.; Finke, S.; Baumgärtner, W.; Mühlberger, E.; Balkema-Buschmann, A.; Dobbelstein, M.: Inhibitors of dihydroorotate dehydrogenase synergize with the broad antiviral activity of 4′-fluorouridine. Antiviral Research 233, 106046 (2025)

Kumar, P.; Zhang, X.; Shaha, R.; Kschischo, M.; Dobbelstein, M.: Identification of antibody-resistant SARS-CoV-2 mutants via N4-Hydroxycytidine mutagenesis. Antiviral Research 231, 106006 (2024)

Aksu, M.; Kumar, P.; Güttler, T.; Taxer, W.; Gregor, K.; Mußil, B.; Rymarenko, O.; Stegmann, K.M.; Dickmanns, A.; Gerber, S. et al.; Reineking, W.; Schulz, C.; Henneck, T.; Mohamed, A.; Pohlmann, G.; Ramazanoglu, M.; Mese, K.; Groß, U.; Ben-Yedidia, T.; Ovadia, O.; Fischer, D.W.; Kamensky, M.; Reichman, A.; Baumgärtner, W.; von Köckritz-Blickwede, M.; Dobbelstein, M.; Görlich, D.: Nanobodies to multiple spike variants and inhalation of nanobody-containing aerosols neutralize SARS-CoV-2 in cell culture and hamsters. Antiviral Research 221, 105778 (2024)